Mass Tort Statistics in US 2026 | Talcum, Roundup & Key Legal Facts

Mass Tort Litigation in America 2026

The mass tort litigation in America 2026 landscape is being defined by a handful of enormous, still-active cases that together represent hundreds of billions of dollars in cumulative liability, with Johnson & Johnson’s talcum powder litigation and Bayer’s Roundup glyphosate litigation sitting at the center of two of the most consequential product liability disputes in American legal history. As of June 2026, over 62,000 talcum powder claims remain pending against Johnson & Johnson, contingent on bankruptcy court approval of an $8.9 billion settlement plan, while the Roundup MDL in the Northern District of California still has 3,909 active plaintiffs as of May 2026 and a separate $7.25 billion class action settlement has been proposed to resolve tens of thousands of additional non-Hodgkin’s lymphoma claims. These two cases alone represent a combined liability exposure that exceeds $20 billion, not counting the additional mass torts active in 2026 including Camp Lejeune water contamination, hair relaxer litigation, PFAS/AFFF contamination, and paraquat.

What makes mass tort litigation in America 2026 particularly volatile is the US Supreme Court’s January 16, 2026 grant of certiorari in the Roundup preemption case, agreeing to review whether federal EPA labeling standards preempt state failure-to-warn claims. A ruling in Bayer’s favor could dismiss or significantly limit tens of thousands of remaining Roundup claims nationwide, while a ruling against the company would confirm that state-court litigation can proceed despite EPA’s position that glyphosate does not require a cancer warning. The decision, expected as early as June 2026, represents the single most consequential pending legal development for any active mass tort in the country and has put both plaintiff firms and defense counsel on alert across the entire toxic tort landscape.

Interesting Facts About Mass Tort Litigation 2026

Before the detailed talcum, Roundup, and broader mass tort breakdowns, here are the most important verified headline figures defining the 2026 mass tort picture.

Data Source: Mass Tort Ad Agency talcum 2026 report, March 31, 2026; Seeger Weiss $7.25B settlement announcement, February 2026; Motley Rice Roundup MDL tracker, May 2026; Wisner Baum Roundup history; TorHernan Law Roundup June 2026 update.

The $8.9 billion talcum powder settlement and the $7.25 billion Roundup class action settlement, both proposed in the 2025-2026 period, represent two of the largest proposed mass tort resolutions in American legal history, and neither is fully finalized as of this writing. The J&J talc settlement requires bankruptcy court approval under the company’s third attempt to use the controversial “Texas Two-Step” bankruptcy strategy to ring-fence its talc liability within a newly created subsidiary while keeping the parent company operating. Courts have previously rejected this approach in J&J’s first two attempts, and the current proceeding remains one of the most closely watched bankruptcy law questions in the country, since its outcome will determine whether the 62,000+ claimants receive the proposed $8.9 billion or whether their cases return to individual MDL litigation with potentially unlimited liability exposure for J&J.

The Roundup $7.25 billion class action proposal was announced on February 18, 2026 and is structured to provide compensation to individuals diagnosed with non-Hodgkin’s lymphoma (NHL) after exposure to Roundup, while also preserving “important exit rights” for claimants who do not wish to participate. The proposal arrived simultaneously with the Supreme Court’s January 16, 2026 certiorari grant in the preemption case, making the settlement’s attractiveness to plaintiffs partly dependent on how they assess the risk that the Supreme Court’s ruling could undermine the legal foundation of their underlying state-court claims.

Talcum Powder Mass Tort Statistics in US 2026

J&J TALCUM POWDER LITIGATION: KEY FIGURES (2026)
=========================================================
Total Active Claims                  | ████████████████████████████████████████ 62,000+
Conditions Alleged                   | ████████████████████████████████████████ Ovarian cancer + mesothelioma
Proposed Settlement Amount           | ████████████████████████████████████████ $8.9B
J&J Bankruptcy Strategy              | ████████████████████████████████████████ 3rd attempt (Texas Two-Step)
Bankruptcy Court Approval Status     | ████████████████████████████████████████ Pending, June 2026
Prior J&J Talc Verdicts (if back to trial):
  Imerys Talc Bankruptcy (context)   | ████████████████████████████████████████ Predecessor resolved
=========================================================
TALC-ASBESTOS CONTAMINATION ALLEGATION
Key Claim                            | ████████████████████████████████████████ Asbestos contamination of talc → mesothelioma
Ovarian Cancer Claim                 | ████████████████████████████████████████ Talc particles migrate to ovaries → cancer
WHO / IARC Classification (2024)     | ████████████████████████████████████████ Talc classified as "possibly carcinogenic to humans"
=========================================================

Data Source: Mass Tort Ad Agency Talcum Powder Lawsuit 2026, March 31, 2026; Wisner Baum talcum litigation overview; IARC Monographs on talc, 2024.

The talcum powder mass tort statistics in US 2026 reflect a litigation saga now spanning more than a decade, with J&J having already paid out billions in individual verdicts and settlements before its current bankruptcy consolidation strategy. The core legal theory across all 62,000+ active claims rests on two distinct but related allegations: first, that perineal use of talcum powder is causally linked to ovarian cancer, and second, that asbestos contamination of talc products caused mesothelioma in a separate population of plaintiffs. These two pathways have different scientific evidentiary bases and different regulatory histories, but both have survived Daubert challenges in multiple federal and state courts, establishing that the scientific causation question is at minimum genuinely disputed rather than conclusively settled in either direction.

The $8.9 billion settlement figure represents J&J’s attempt to provide certain, structured compensation to claimants while capping the company’s total talc liability and preventing the unpredictable exposure of ongoing individual trials, several of which have produced verdicts in the hundreds of millions of dollars. The bankruptcy court approval process is the critical gating event: if approved, the settlement creates a structured claims resolution facility. If rejected for a third time, the litigation could generate another decade of individual and MDL trials with the potential for cumulative verdicts that dwarf even the $8.9 billion settlement figure, a scenario that both sides have strong incentives to avoid.

Roundup Glyphosate Mass Tort Statistics in US 2026

ROUNDUP / GLYPHOSATE LITIGATION: KEY FIGURES (2026)
=========================================================
Total Roundup Lawsuits Filed (vs Bayer)   | ████████████████████████████████████████ 100,000+
Current MDL Pending Actions (May 2026)     | ████ 3,909
Prior Settlement (2020, Bayer)              | ████████████████████████████████████████ $10.9B (125,000 cases)
Proposed Class Settlement (Feb 2026)         | ████████████████████████████████████████ $7.25B
Supreme Court Cert Grant                       | ████████████████████████████████████████ Jan 16, 2026
Decision Expected                               | ████████████████████████████████████████ By June 2026
Pilliod Verdict (California, post-reduction)    | ████████████████████████████████████████ $87M
Missouri $1.56B Verdict (reduced to $611M)       | ████████████████████████████████████████ $611M+ (interest: $700M+)
=========================================================
BAYER FINANCIAL IMPACT
Q3 2024 Loss (Bayer)                         | ████████████████████████████████████████ $4.45B
Share Price Decline (since Monsanto purchase) | ████████████████████████████████████████ Significant
=========================================================

Data Source: Seeger Weiss $7.25B announcement, February 18, 2026; Motley Rice MDL tracker, May 2026; TorHernan Law Roundup June 2026 update; Wisner Baum Roundup settlement history; LawFold Roundup 2026 guide.

The Roundup glyphosate mass tort statistics in US 2026 tell the story of litigation that has already extracted the single largest product liability settlement in pesticide history ($10.9 billion in 2020) and yet continues to generate new claims and large verdicts nearly a decade after the first jury found for the plaintiff. With over 100,000 lawsuits filed in total and the MDL still carrying 3,909 active cases as of May 2026, Bayer’s legal exposure from Monsanto’s glyphosate herbicide has become one of the most significant ongoing corporate liabilities in the world, contributing to a $4.45 billion net loss in Q3 2024 alone and prompting the company to explore reformulating residential Roundup without glyphosate for future sales, a move that wouldn’t affect existing claims from past exposure.

The Missouri Supreme Court’s refusal to hear Bayer’s appeal in May 2026, effectively finalizing a $611 million judgment (now exceeding $700 million with 9% annual interest) against the company in a case where four plaintiffs alleged NHL from Roundup exposure, demonstrates that even outside the federal MDL system, state court litigation continues to produce substantial verdicts. The pending Supreme Court preemption decision is the wildcard that could reshape everything: if the court rules that federal EPA labeling decisions preempt state failure-to-warn claims, the legal foundation of most remaining Roundup lawsuits would be significantly undermined, potentially making the $7.25 billion proposed class settlement an extraordinarily favorable outcome for claimants who might otherwise receive far less if the preemption argument succeeds.

Other Major Mass Torts in US 2026

OTHER ACTIVE MASS TORTS (2026 STATUS)
=========================================================
Camp Lejeune Water Contamination
  Active Claims (2026)          | ████████████████████████████████████████ Active MDL
  Contaminants                    | ████████████████████████████████████████ TCE, PCE, benzene (1953-1987)
  Eligibility                      | ████████████████████████████████████████ Served 30+ days, 1953-1987
---------------------------------------------------------
Hair Relaxer Litigation
  Active Claims (2026)          | ████████████████████████████████████████ 8,000+ plaintiffs
  Injury Alleged                  | ████████████████████████████████████████ Uterine cancer from chemical relaxers
---------------------------------------------------------
PFAS / AFFF Firefighting Foam
  Status (2026)                  | ████████████████████████████████████████ Active MDL
  Injuries Alleged                | ████████████████████████████████████████ Cancers from PFAS exposure
---------------------------------------------------------
3M Earplug (CAEv2)
  Prior Settlement (2023)        | ████████████████████████████████████████ $6.01B (240,000 veteran claimants)
  2026 Status                     | ████████████████████████████████████████ Payout ongoing
=========================================================

Data Source: Mass Tort Ad Agency 2026 active torts overview, March 2026; Seeger Weiss case portfolio 2026; LawFold active mass tort guide 2026.

The other major mass torts in US 2026 landscape shows a litigation environment where new torts are consistently emerging even as older ones approach resolution. Camp Lejeune, covering military personnel who were exposed to contaminated water at the North Carolina Marine Corps base between 1953 and 1987, remains one of the most geographically and legally complex torts active in 2026, with eligibility requiring documentation of at least 30 days of service on base during the qualifying period and a diagnosed qualifying illness from a list that includes multiple cancers and neurological conditions. The 3M Combat Arms earplug settlement of $6.01 billion, reached in 2023 to resolve 240,000 veteran hearing damage claims, stands as the largest mass tort settlement in US history for a military product defect and continues to shape how courts and MDL administrators approach large-volume military-related torts.

The hair relaxer litigation, with over 8,000 plaintiffs alleging uterine cancer from the use of chemical hair straightening products, is one of the fastest-growing mass torts of the 2024-2026 cycle, having grown from initial filings to a multi-thousand-plaintiff MDL in under two years. The Paraquat litigation, alleging that exposure to the herbicide causes Parkinson’s disease, and the Philips CPAP recall MDL, alleging cancer risk from degrading polyurethane foam in recalled sleep apnea devices, both represent substantial ongoing liabilities that will likely produce multi-billion-dollar resolutions in the 2026-2028 window, adding to a mass tort landscape that continues to generate one of the highest sustained levels of complex litigation in American legal history.

Mass Tort Legal Process and MDL Statistics in US 2026

MDL SYSTEM: KEY OPERATIONAL STATISTICS (2026)
=========================================================
Share of Federal Civil Cases That Are MDLs       | ████████████████████████████████████████ ~65-70% (consistently)
Largest MDL by Case Count (Active, 2026)          | ████████████████████████████████████████ Varied by month
Cases Settling vs Going to Trial (mass torts)      | ████████████████████████████████████████████████████████████████████████████████████████████████ ~95%+ settle
Average Time from Filing to MDL Resolution         | ████████████████████████████████████████ 3-10+ years
=========================================================
2026 ACTIVE MDL DOCKETS (SELECTED)
Roundup (N.D. Cal.)         | ████████████████ 3,909 cases (May 2026)
Talcum Powder (D. N.J.)     | ████████████████████████████████████████ 62,000+ (in bankruptcy)
AFFF/PFAS                   | ████████████████████████████████████████ Active (thousands)
Camp Lejeune                | ████████████████████████████████████████ Active MDL
Hair Relaxer (N.D. Ill.)    | ████████████████████████████████████████ 8,000+ cases
=========================================================

Data Source: Seeger Weiss mass tort litigation overview, 2026; Motley Rice MDL tracker; LawFold mass tort 2026 guide; Mass Tort Ad Agency active torts report, 2026.

The mass tort legal process and MDL statistics in US 2026 show a federal court system where multidistrict litigation now accounts for approximately 65-70% of all civil cases on the federal docket, a proportion that has grown dramatically over the past two decades as the MDL mechanism has become the preferred tool for consolidating related claims from hundreds of thousands of plaintiffs into a single coordinated proceeding. The ~95% settlement rate for mass tort cases reflects the practical reality that taking even a fraction of these claims to individual trial would be logistically and economically impossible for both the courts and the defendants, creating strong structural incentives for negotiated resolution even when the underlying science or liability questions remain contested.

The 3 to 10-plus year average timeline from initial filing to final resolution is a critical practical reality for claimants, many of whom are seriously ill at the time of filing and face genuine uncertainty about whether they will live to see their case resolved. This dynamic has created both the pressure for defendants to offer early settlements and the plaintiff bar’s strategic management of bellwether trials (the small number of cases selected to go to trial to test case strength and establish settlement benchmarks) that defines the rhythm of every major MDL. The $10.9 billion Roundup settlement of 2020 and the proposed $7.25 billion class action of 2026 both reflect this same dynamic: after bellwether trial losses made the litigation risk clear, Bayer’s rational strategy became negotiated resolution rather than continued trial exposure, a pattern that has now been replicated in nearly every major mass tort of the past decade.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE